Globe Life Inc. logo GL - Globe Life Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
1
BUY 9
HOLD 11
SELL 7
STRONG
SELL
0
| PRICE TARGET: $172.80 DETAILS
HIGH: $185.00
LOW: $157.00
MEDIAN: $175.00
CONSENSUS: $172.80
DOWNSIDE: 3.11%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate
Trading 34.9% below fair value
Current Price $178.34
Bear Case $251.15 40.8% upside ($251.15 - $178.34) / $178.34 = 40.8% ROTCE 14.6% → 3.67x TBV
Fair Value $274.04 53.7% upside ($274.04 - $178.34) / $178.34 = 53.7% ROTCE 19.4% → 4.00x TBV
Bull Case $274.04 53.7% upside ($274.04 - $178.34) / $178.34 = 53.7% ROTCE 22.4% → 4.00x TBV

Adjust Assumptions

19.4%
6.9%

Key Value Driver

ROTCE (19.4%) vs. cost of equity (6.9%)

Implied Market Multiple 2.32x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $172.80 from 28 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $274.04 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $172.80 (from 28 analysts). Our estimate is 78% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly